经肝圆韧带裂入路肝切除术的临床疗效

Clinical effect of fissure for ligamentum teres hepatic approach in hepatectomy

  • 摘要: 目的:探讨经肝圆韧带裂入路肝切除术的临床疗效。
    方法:采用横断面调查研究方法。收集2009年2月至2013年12月四川大学华西医院85例采用经肝圆韧带裂入路行肝切除术患者的临床资料。85例患者中,肝细胞癌61例,肝内胆管结石12例,胆管细胞癌6例,转移性肝癌6例。解剖肝圆韧带裂,处理肝圆韧带裂内的门静脉、肝动脉和胆管,降肝门,离断肝实质,行肝左外叶、左半肝、肝中叶及肝左、右三叶切除术等。记录患者手术方式、手术时间、术中出血量、术中输血情况、术后引流管拔除时间、并发症发生情况。采用门诊和电话方式进行随访,随访时间截至2015年8月,观察患者肿瘤复发、转移及生存情况。正态分布的计量资料以±s表示,偏态分布的计量资料以M(范围)表示。采用KaplanMeier法计算生存率。
    结果:85例患者均采用经肝圆韧带裂成功完成肝切除术,其中行肝左外叶切除术19例(肝细胞癌9例、肝内胆管结石6例、胆管细胞癌1例、转移性肝癌3例),左半肝切除术20例(肝细胞癌8例、肝内胆管结石5例、胆管细胞癌4例、转移性肝癌3例),左半肝+肝尾状叶切除术5例(肝细胞癌3例、肝内胆管结石1例、胆管细胞癌1例),肝中叶切除术14例(均为肝细胞癌),肝三叶切除术27例(均为肝细胞癌,行肝左三叶切除术15例、肝右三叶切除术12例)。无患者发生围术期死亡。中位手术时间为280 min(95~430 min),中位术中出血量为450 mL(200~3 200 mL), 术中输血例数为18例。术后腹腔引流管中位拔除时间为3 d(2~5 d)。术后11例患者发生并发症,其中肺部感染6例、腹腔积液4例、腹腔感染 1例,均经对症保守治疗后恢复。术后无腹腔内大出血、胆汁漏、肝衰竭等并发症发生。术后1个月内无患者死亡。79例患者获得术后随访,随访率为92.9%(79/85)。中位随访时间为38个月(18~53个月)。患者1年总体生存率和1年无病生存率分别为79.0%和65.0%,3年总体生存率和3年无病生存率分别为56.0%和34.0%。
    结论:经肝圆韧带裂入路行肝切除术安全有效、简便易行,近期疗效好。

     

    Abstract: Objective:To investigate the clinical effect of fissure for ligamentum teres hepatic (LTH) approach in hepatectomy.
    Methods:The method of crosssectional study was adopted. The clinical data of the 85 patients undergoing hepatectomy through fissure for LTH approach who were admitted to the West China Hospital of Sichuan University from February 2009 to December 2013 were collected. Among all the 85 cases, there were 61 of hepatocellular carcinoma, 12 of intrahepatic bile duct stones, 6 of bile duct cellular carcinoma and 6 of metastatic hepatic carcinoma. The operations involved dissecting fissure for LTH, dealing with portal vein, hepatic artery and bile duct inside the fissure, lowering the hepatic portal, mutilating hepatic parenchyma, and undergoing the hepatic left lateral lobectomy, left hemihepatectomy, mesohepatectomy, hepatic left and-/or right trisegmentectomy. Operation method, operation time, volume of intraoperative blood loss, intraoperative blood transfusion, postoperative drainagetube removal time and complications were recorded. The followup including recurrence and metastasis of tumor and survival of patients was conducted by outpatient examination and telephone interview up to August 2015. Measurement data with normal distribution were presented as ±s. Measurement data with skewed distribution were presented as M (range). The survival rate was caculated by KaplanMeier method.
    Results:The 85 cases of hepatectomy were successfully completed through fissure for LTH approach, including 19 cases of hepatic left lateral lobectomy (9 with hepatocellular carcinoma, 6 with intrahepatic bile duct stones, 1 with bile duct cellular carcinoma, 3 with metastatic hepatic carcinoma), 20 cases of left hemihepatectomy (8 with hepatocellular carcinoma, 5 with intrahepatic bile duct stones, 4 with bile duct cellular carcinoma, 3 with metastatic hepatic carcinoma), 5 cases of left hemihepatectomy+caudate lobectomy (3 with hepatocellular carcinoma, 1 with intrahepatic bile duct stones, 1 with bile duct cellular carcinoma), 14 cases of mesohepatectomy (14 with hepatocellular carcinoma) and 27 cases of hepatic left and-/or right trisegmentectomy due to hepatocellular carcinoma (15 of hepatic left trisegmentectomy and 12 of hepatic right trisegmentectomy). No perioperative death occurred. The median operation time was 280 minutes (range, 95- 430 minutes). The median volume of intraoperative blood loss was 450 mL (range, 200-3 200 mL).There were 18 cases of intraoperative blood infusion. The postoperative peritoneal drainagetube removal time was 3 days (range, 2 -5 days). Eleven patients with postoperative complications recovered after symptomatic conservative treatment, including 6 with lung infection, 4 with peritoneal effusion and 1 with abdominal infection. There was no case of intraabdominal bleeding, bile leakage or hepatic failure. No patient died within 1 month after operation. Seventynine patients were followed up for a median time of 38 months (range, 18-53 months) with a followup rate of 92.9%(79/85). The 1year overall survival rate and 1year diseasefree survival rate were 79.0% and 65.0%, and the 3year overall survival rate and 3year diseasefree survival rate were 56.0% and 34.0%, respectively.
    Conclusion:Hepatectomy through fissure for LTH approach is safe, effective and easily operable, with a good shortterm outcome.

     

/

返回文章
返回